News & Events

Grant Success
The new network research collaboration 'Big Brain' - a significant initiative that aims to shape research and clinical care for children with neurodevelopmental disorders has received a three year $510,000 grant from the Ainsworth Foundation through the Sydney Children's Hospitals Foundation.  'Big Brain' is a collaboration led by Prof Russell Dale, Dr Michelle Farrar and Prof Adam Guaste...
Read more
Awards
Congratulations to Professor Joshua Burns, Director of the Paediatric Gait Analysis Service of NSW and the Humpty Dumpty Gait Lab at the Sydney Children’s Hospitals Network, and Professor of Paediatric Neuromuscular Rehabilitation at the University of Sydney recent major successes! Prof Burns has been awarded the Vice-Chancellor’s Award for Outstanding Research Higher Degree Supervision. The a...
Read more
Events
‘Approximately one in ten children in Australia meet criteria for a neurodevelopmental disorder’ Professor Adam Guastella, Michael Crouch Chair in Child and Youth Mental Health, clinical psychologist and clinical trials specialist based at Westmead Children’s Hospital and the Brain and Mind Centre, University of Sydney is leading a national effort where leading experts from universities and he...
Read more
- Achieved primary efficacy measure with both EPIDIOLEX doses as compared to placebo - - Represents the fifth consecutive positive Phase 3 pivotal trial for EPIDIOLEX - - Expect to file sNDA in Q4 2019 -   Carlsbad, CA, May 6, 2019: GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the scien...
Read more
Medicinal Cannabis
Medicinal Cannabis: Positive results in treatment of children with seizures from Tuberous Sclerosis Complex (TSC) A phase 3 clinical trial has shown that the cannabis-based medicine Epidiolex ® (cannabidiol oral solution or CBD) manufactured and supplied by GW pharmaceuticals was successful in the treatment of seizures associated with Tuberous Sclerosis Complex (TSC). TSC is a rare genetic...
Read more
Medicinal cannabis
A phase III clinical trial has shown the cannabis-based medicine Epidiolex® (cannabidiol oral solution) to reduce seizures in children with Dravet syndrome, a rare and severe form of childhood-onset epilepsy.  Sydney Children’s Hospital, Randwick, was one of two sites in Australia to take part in the international study, which reinforced the safety and efficacy of the drug in reducing sei...
Read more
Medicinal Cannabis
Findings into the safety of Epidiolex®, an experimental cannabis-based treatment for severe drug-resistant epilepsy in children, have been published in the Medical Journal of Australia. Under the NSW Government funded Compassionate Access Scheme, children with the most severe forms of childhood epilepsy, who are too sick to participate in a clinical trial, have an opportunity to access a canna...
Read more
Researcher Profile
Dr Tejaswi Kandula is paediatric neurologist at Sydney Children’s Hospital, Randwick, with a special interest in researching peripheral neuropathy in childhood cancer survivors. Dr Kandula recently published her fourth paper on the subject in the American Medical Association’s top-ranking neurology journal, JAMA Neurology, which generated worldwide interest and has been viewed more than 4000 t...
Read more
Research
Dr Monkol Lek is a leading researcher in muscular dystrophy, a rare genetic disease affecting nerves and muscles around the body.  Dr Lek is all too familiar with the disease, having suffered from muscle weakness in his legs while at university, which led, over ten years later, to a diagnosis of limb girdle muscular dystrophy. After leaving his job as a computer engineer and retraining as...
Read more
  • 20 June 2018
Big news! The Institute of Neuroscience and Muscle Research (INMR) has a new name: Kids Neuroscience Centre.  The new brand identity reflects the joint mission of Kids Research and the Centre to drive excellence in paediatric health. While the name has changed, the vision to improve the lives of children affected by muscle, nerve and brain disease t...
Read more